SPONSOR

VINCENT NELSON

WEB DESIGNER

NATHAN WILLIAMS

WEB DEVELOPER

THOMAS CALVIN

ACCOUNT MANAGER

MEET THE SPEAKERS

Dr. Jihad Inshasi

Prof. Dr. Mohammad Ali Sahraian

Prof. Dr. Dina Abdelgawad Zamzam

Who should attend?

Neurologists, Primary Care Physicians, General Practitioners, Nurses, Allied Health, Professionals, Pharmacists, Physiotherapists, Social workers or any other personnel involved in the management of rehabilitation physicians, Radiologists, Psychiatrists, Internal Medicine, Physicians, Students

Sponsored By:

Biologix FZco, a company organized and existing under the laws of the United Arab Emirates, was incorporated in the Dubai Airport Free Zone in September 2002 as a regional supplier and promoter of Biotechnology products.

Biologix FZco is a service provider to Pharmaceutical and Biotech companies and performs Named Patient Supply, market access, promotion and sales, detailing, logistics, registration, medical and disease awareness activities including Pharmacovigilance and Risk Management Plan, on behalf of its partners in the Middle East and North Africa (MENA) markets.

Biologix main partners include: Amarin, Biogen, Cardiome, Celgene, Chiesi, Ipsen, Jazz Pharmaceuticals, Takeda, Shire, Nalpropion, Pharmaxis and Alexion.

Biologix premises are being regularly audited by the Ministry of Health in the United Arab Emirates and by its Principals and business partners. Furthermore, the company has acquired the ISO 9001:2000 Certification and the Trace Certification.

For the past 15 years, Biologix has been and continues to address the needs of patients in the MENA suffering from serious and critical conditions by ensuring a fast supply of innovative products of the highest quality.

VISIT WEBSITE

Managed By:

The MCO leverages upon the experience gained through years of organizing, we have the ability to listen, learn and develop events in line with the expectations of the industry that we serve. With our infinite understanding of the current market, support and guidance from local stakeholders and KOL advisors we bring together state of the art medical events.

MCO events offer a benchmark to the industry for quality and content and lead the way in identifying cutting edge knowledge which is relevant to all the participants. Our experience of delivering high-quality events has enabled us to build a strong portfolio of customized events that we deliver for key clients looking to get that extra advantage over their competitors. Our knowledge of the markets, accreditations, marketing messages and logistics management within the healthcare sector makes us the perfect choice for companies looking to deliver premium events for their target audience.

VISIT WEBSITE

FIND US HERE

P.O Box 44548, 5th Floor, Musallam Salem Mohamed Al Ameri Building, Al Falah Street, Al Danah, Abu Dhabi, United Arab Emirates

Eric Fernando

Program Coordinator

+971 2 658 8717 | +971 55 586 0152 | eric@mco.ae

SPONSOR

Building on a 50-year heritage in respiratory care, our ambition is to transform the treatment of asthma and chronic obstructive pulmonary disease (COPD) by driving earlier, biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death.

Underpinning chronic lung diseases is an altered immune system. AstraZeneca is following the science of common pathways and underlying disease drivers from respiratory disease into immunology-driven disease areas.

The disease areas we’re targeting include rheumatology (including type 1 interferon-driven diseases such as lupus), dermatology, gastrointestinal diseases and inflammatory diseases driven by eosinophilic immune dysfunction. Our ambition is to achieve disease modification and durable remission in these diseases for millions of patients worldwide.

VISIT WEBSITE

SPONSOR

VINCENT NELSON

NATHAN WILLIAMS

THOMAS CALVIN

MEET THE SPEAKERS

Dr. Jihad Inshasi

Prof. Dr. Mohammad Ali Sahraian

Prof. Dr. Dina Abdelgawad Zamzam

AGENDA

Who should attend?

FIND US HERE

SPONSOR

Building on a 50-year heritage in respiratory care, our ambition is to transform the treatment of asthma and chronic obstructive pulmonary disease (COPD) by driving earlier, biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death.